Пути решения проблемы статистики сердечной недостаточности в клинической практике

Для организации медицинской помощи в системе здравоохранения важно знать потребность в объемах ее отдельных видов, в том числе количестве госпитализаций и используемых дорогостоящих технологий. У больных с сердечно-сосудистыми заболеваниями синдром сердечной недостаточности (СН) часто определяет тяжесть состояния и прогноз, но, являясь осложнением основного заболевания, он не попадает в статистические отчеты и счета за оказание медицинской помощи в системе обязательного медицинского страхования. В данной статье представлены проблемы оценки распространенности и смертности от СН в различных странах и согласованная позиция авторов по вопросам подходов к кодированию СН в информационных системах, обеспечивающих учет заболеваемости и смертности.

1. Boorsma EM, Rienstra M, van Veldhuisen DJ, van der Meer P. Residual confounding in observational studies: new data from the old DIG trial. European Heart Journal. 2019;40(40):3342–4. DOI: 10.1093/eurheartj/ehz527

2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129–200. DOI: 10.1093/eurheartj/ehw128

3. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137–46. DOI: 10.1136/hrt.2003.025270

4. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289(2):194–202. DOI: 10.1001/jama.289.2.194

5. Bleumink GS, Knetsch AM, Sturkenboom MCJM, Straus SMJM, Hofman A, Deckers JW et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. European Heart Journal. 2004;25(18):1614–9. DOI: 10.1016/j.ehj.2004.06.038

6. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. European Journal of Heart Failure. 2002;4(4):531–9. DOI: 10.1016/S1388-9842(02)00034-X

7. Van Riet EES, Hoes AW, Limburg A, Landman MAJ, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion: Unrecognized HF in older persons with shortness of breath on exertion. European Journal of Heart Failure. 2014;16(7):772–7. DOI: 10.1002/ejhf.110

8. Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58 (6S): 8–164. DOI: 10.18087/cardio.2475

9. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP et al. Heart Disease and Stroke Statistics-2019 Update: A Report from the American Heart Association. Circulation. 2019;139(10):e56–528. DOI: 10.1161/CIR.0000000000000659

10. Moscow city compulsory medical insurance Fund. Tariff agreement for 2020. Av. at: https://www.mgfoms.ru/medicinskie-organizacii/tarifi/2020. https:// www.mgfoms.ru/medicinskie-organizacii/tarifi/2020]

11. OECD. Statistics. Health Care Utilisation: Hospital discharges by diagnostic categories. [Internet] Available at: https://stats.oecd.org/ 12. Bytyçi I, Bajraktari G. Mortality in heart failure patients. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 2015;15(1):63–8. DOI: 10.5152/akd.2014.5731

12. Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Population Health Metrics. 2010;8(1):9. DOI: 10.1186/1478-7954-8-9

13. Center for Disease Control and Prevention. Underlying Cause of Death, 1999-2018 Request. [Internet] Available at: https://wonder. cdc.gov/ucd-icd10.html 15. Laribi S, Aouba A, Nikolaou M, Lassus J, Cohen-Solal A, Plaisance P et al. Trends in death attributed to heart failure over the past two decades in Europe. European Journal of Heart Failure. 2012;14(3):234– 9. DOI: 10.1093/eurjhf/hfr182

14. Zayratyants O.V., Vasilyeva E.Yu., Mikhaleva L.M., Olenev A.S., Cherkasov S.N., Chernyaev A.L. et al. Rules for the formulation of pathoanatomic diagnosis, selection and coding of ICD10 causes of death. Methodical recommendations No. 45-56. Av. at: https://mosgorzdrav.ru/ru-RU/science/default/search.html?phrase=&year=2019&group_id=33&type=0. 2019. https://mosgorzdrav.ru/ru-RU/science/default/search.html?phrase=&year=2019&group_id=33&type=0]

15. Zayratyants O.V. Improving in reliability of data on causes of death – an important condition for achievement of target indicators of decline in mortality from the separate reasons. Russian Journal of Forensic Medicine. 2018;4(3):4–9.

16. Ministry of Health of Russian Federation. Methodological recommendations for the final comparison of the clinical and pathological/forensic diagnoses. Age group: children/adults. MR 109. Av. at: https://democenter.nitrosbase.com/clinrecalg5/Files/recomend/МР109.pdf. 2019. https://democenter.nitrosbase.com/clinrecalg5/Files/recomend/МР109.pdf